| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 03/18/2004 | WO2003017818A3 Management of gastro-intestinal disorders |
| 03/18/2004 | US20040054172 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids |
| 03/18/2004 | US20040052857 Vesicle encapsulating an aqueous system of a polymer and can exist as more than one phase depending on temperature and composition |
| 03/18/2004 | US20040052728 Diagnostic imaging |
| 03/18/2004 | US20040052727 Radiolableled selective androgen receptor modulators andtheir use in prostate cancer imaging and therapy |
| 03/18/2004 | CA2497548A1 Preparation of m(co)3-complexes by solid phase techniques via metal assisted cleavage from the solid support |
| 03/18/2004 | CA2496566A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | CA2495442A1 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same |
| 03/17/2004 | EP1397387A1 Antibodies specific for cd44v6 |
| 03/17/2004 | EP1397339A1 (ethylene)-(propylene)-triaminepentaacetic acid derivatives, process for their production, and their use for the production of pharmaceutical agents |
| 03/17/2004 | EP1071684B1 IMIDAZO 1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS |
| 03/17/2004 | EP0986373B1 Drug targeting system, method of its preparation and its use |
| 03/17/2004 | EP0915974B1 Modified tie-2-receptor ligands |
| 03/17/2004 | CN1482922A Device for synthesis of radiopharmaceutical products |
| 03/17/2004 | CN1482887A Method and apparatus for therapeutic emr treatment of the skin |
| 03/16/2004 | US6706947 Method for screening for agents against cancer using an immunosuppression animal model |
| 03/16/2004 | US6706880 Used as imaging or pharmaceutical agents, in the diagnosis and therapy of drug addiction, depression, anorexia and neurodegenerative diseases |
| 03/16/2004 | US6706713 Conjugate for treating inflammatory infectious and/or skin diseases |
| 03/16/2004 | US6706252 Seeking and destroying such as bacteria or viruses |
| 03/16/2004 | US6706251 High ratio of perrhenate to thiosulphate and cysteine; higher final ph; tc-99m material; smaller particle size distribution |
| 03/16/2004 | CA2100709C Method and means for site directed therapy |
| 03/11/2004 | WO2004020011A1 Embolization |
| 03/11/2004 | WO2004019999A2 Agent delivery particle |
| 03/11/2004 | WO2004019998A1 Methods for functional kidney imaging using dendrimer conjugate contrast agents |
| 03/11/2004 | WO2003051395A3 Edg-receptor agonist for the treatment of hypertension |
| 03/11/2004 | WO2002060923A3 B-superfamily conotoxins |
| 03/11/2004 | US20040048798 Especially CTL polypeptides of specific sequences |
| 03/11/2004 | US20040048313 Neutrophil imaging in cystic fibrosis |
| 03/11/2004 | US20040047909 Providing a structure comprising a base material; positioning a bioactive agent; positioning at least one porous layer over bioactive, porous layer being of a thickness adequate to provide a controlled release of bioactive agent |
| 03/11/2004 | CA2496612A1 Embolization |
| 03/10/2004 | EP1395591A1 Corticotropin releasing factor antagonists |
| 03/10/2004 | EP1395226A2 Use of radiopharmaceutical complexes in achieving transplantation tolerance |
| 03/10/2004 | EP1021205B1 Synthesis of ferrocenyl phenyltropane analogs and their radio-transformation to technetium neuroprobes for mapping monoamine reuptake sites |
| 03/10/2004 | EP0918547B1 Radiolabeled annexins |
| 03/10/2004 | CN1141146C Pure beta ray carrying safe microball and its preparation |
| 03/10/2004 | CN1141145C Application of medicine for treating thyroidism accompanied by infiltrative exorbitism |
| 03/09/2004 | CA2216423C Ternary radiopharmaceutical complexes |
| 03/04/2004 | WO2004018066A2 Aqueous two-phase systems for particle manipulation and encapsulation within microscopic volumes |
| 03/04/2004 | WO2004017907A2 Blood clot-targeted nanoparticles |
| 03/04/2004 | WO2004017905A2 Method and apparatus for noninvasively evaluating endothelial function |
| 03/04/2004 | WO2003105762A3 Treating disease using radium-225 |
| 03/04/2004 | WO2003082350A3 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 03/04/2004 | WO2003074566A3 Rs7 antibodies |
| 03/04/2004 | US20040044076 Neutrophil imaging methods in cystic fibrosis |
| 03/04/2004 | US20040044065 Metalloenzyme inhibitor |
| 03/04/2004 | US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders |
| 03/04/2004 | US20040043920 Chelate compound of metal and dithiocarbamate; therapy, diagnosis |
| 03/04/2004 | US20040043030 Polymeric delivery systems |
| 03/04/2004 | US20040043029 Novel antibodies reactive with human carcinomas |
| 03/04/2004 | US20040042963 Biomolecule conjugation strategy using novel water-soluble phosphine-based chelating agents |
| 03/04/2004 | CA2491758A1 Blood clot-targeted nanoparticles |
| 03/03/2004 | EP1393750A2 Conjugates for treating an immune disease |
| 03/03/2004 | EP1392714A1 Steroids as agonists for fxr |
| 03/03/2004 | EP1392676A2 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| 03/03/2004 | EP1392361A1 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26 |
| 03/03/2004 | EP1392360A2 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 03/03/2004 | EP1392359A2 Specific binding proteins and uses thereof |
| 03/03/2004 | EP1169064B1 Method of detecting endometriosis |
| 03/03/2004 | CN1478552A Carrier used for carrying radiation substance and its use method |
| 03/03/2004 | CN1478551A Medicine used in medical breath diagnosis |
| 03/03/2004 | CN1478550A Egg yolk antibody composition for preventing and treating atypical pneumonia and its preparation method |
| 03/02/2004 | US6699675 Marker for inflammatory conditions |
| 03/02/2004 | US6699473 Human anti-epidermal growth factor receptor single-chain antibodies |
| 03/02/2004 | US6699458 Cell membrane permeabilities greater than that of sucrose |
| 02/27/2004 | CA2399781A1 Cellular and molecular basis for anti-alzheimer treatment by blocking mrna dendritic transport from cell body to senile plaque and by this the prevention of senile plaque formation |
| 02/26/2004 | WO2004016231A2 PROTECTION OF PATIENTS LACKING A FUNCTIONAL SPLEEN AGAINST S. PNEUMONIAE WITH PNEUMOCOCCAL SURFACE PROTEIN A (PspA) |
| 02/26/2004 | WO2003035011A3 Multidrug multiligand conjugates for targeted drug delivery |
| 02/26/2004 | WO2002083917A8 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 02/26/2004 | WO2002072636A8 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 02/26/2004 | US20040038412 Measuring expired 13C-labeled carbon dioxide; kits |
| 02/26/2004 | US20040037777 Small dendrimer-based MRI contrast agents are disclosed to accumulate in renal tubules. The accumulation enables visualization of renal structure and function, permitting assessment of structural and functional damage to the kidneys |
| 02/26/2004 | US20040037774 Carrier for carrying radioactive substances and methods for using the same |
| 02/26/2004 | US20040037773 Method for detecting abnormal tissue using enhanced radiopharmaceutical uptake |
| 02/25/2004 | EP1390549A1 Metal-zirconia composite coating |
| 02/25/2004 | EP1390406A2 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 02/25/2004 | EP1390405A2 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
| 02/25/2004 | EP1390081A2 Therapeutic and diagnostic compounds, compositions, and methods |
| 02/25/2004 | EP1390080A1 Azo compounds for type i phototherapy |
| 02/25/2004 | EP1390077A2 Treatment and diagnosis of macrophage mediated disease |
| 02/25/2004 | EP1284757B1 System comprising a carrier substrate and a ti/p or. ai/p coating |
| 02/25/2004 | EP0869976B1 Design of hormone-like antibodies with agonistic and antagonistic functions |
| 02/25/2004 | CN1139405C Preparation process of source core of iodine-125 granule sealed seed source |
| 02/24/2004 | US6696457 Morphinoid compounds |
| 02/24/2004 | US6696276 Vasopermeability-enhancing conjugates |
| 02/24/2004 | US6696089 Nanogel networks including polyion polymer fragments and biological agent compositions thereof |
| 02/24/2004 | US6696039 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 02/24/2004 | CA2199399C .beta.,.beta.'-dihydroxy meso-substituted chlorins, isobacteriochlorins, bacteriochlorins, and methods for making the same from .beta.,.beta.'-unsubstituted tetrapyrrolic macrocyles |
| 02/19/2004 | WO2003065882A3 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts |
| 02/19/2004 | WO2003020212A3 Treatment for central nervous system disorders |
| 02/19/2004 | WO2003000113A9 Compositions and methods for the diagnosis and treatment of tumor |
| 02/19/2004 | US20040034246 Radiofluorinated imaging agents which are utilzed in Positron Emission Tomography for diagonsis of Parkinson's disease |
| 02/19/2004 | US20040033520 Diagnosing metastatic colorectal, stomach and/or esophageal cancer in vitro; immunoassay; radioimaging tumors; immunotherapeutics; genetic vaccines |
| 02/19/2004 | US20040033229 PSMA antibodies and protein multimers |
| 02/19/2004 | US20040033197 Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts |
| 02/19/2004 | US20040033196 Synthesis of 17F labeled fluoroalkanes |
| 02/19/2004 | US20040033195 Vitamin-targeted imaging agents |
| 02/18/2004 | EP1389209A1 Folate mimetics and folate-receptor binding conjugates thereof |
| 02/18/2004 | EP1389090A2 Diagnostic imaging compositions, their methods of synthesis and use |
| 02/18/2004 | EP1133494B1 8-azabicyclo 3.2.1]oct-2-ene and -octane derivatives |
| 02/18/2004 | EP1075287B1 Positron emission tomography using gallium-68 chelates |